FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * SCHULER JACK W   2. Issuer Name and Ticker or Trading Symbol Neos Therapeutics, Inc. [NEOS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O NEOS THERAPEUTICS, INC., 2940 N. HWY 360 3. Date of Earliest Transaction (Month/Day/Year) 07/28/2015 (Street) GRAND PRAIRIE, TX 75050 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 07/28/2015   C   72,087 A (1) 72,087 D   Common Stock 07/28/2015   C   189,159 A (1) 261,246 D   Common Stock 07/28/2015   C   783,332 A (1) 1,044,578 D   Common Stock 07/28/2015   C   41,665 A (1) 1,086,243 I See Footnote (2) Common Stock 07/28/2015   C   41,665 A (1) 1,127,908 I See Footnote (3) Common Stock 07/28/2015   C   41,665 A (1) 1,169,573 I See Footnote (4) Common Stock 07/28/2015   C   41,665 A (1) 1,211,238 I See Footnote (5) Common Stock 07/28/2015   C   41,665 A (1) 1,252,903 I See Footnote (6) Common Stock 07/28/2015   P   20,000 A $ 15 1,279,903 I See Footnote (7)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Preferred Stock	(1)	07/28/2015		C			173,009	(1)	(1)	Common Stock	72,087	(1)	0	D
Series B-1 Preferred Stock	(1)	07/28/2015		C			453,982	(1)	(1)	Common Stock	189,159	(1)	0	D
Series C Preferred Stock	(1)	07/28/2015		C			1,880,000	(1)	(1)	Common Stock	783,332	(1)	500,000	D
Series C Preferred Stock	(1)	07/28/2015		C			100,000	(1)	(1)	Common Stock	41,665	(1)	400,000	I	See Footnote (2)
Series C Preferred Stock	(1)	07/28/2015		C			100,000	(1)	(1)	Common Stock	41,665	(1)	300,000	I	See Footnote (3)
Series C Preferred Stock	(1)	07/28/2015		C			100,000	(1)	(1)	Common Stock	41,665	(1)	200,000	I	See Footnote (4)
Series C Preferred Stock	(1)	07/28/2015		C			100,000	(1)	(1)	Common Stock	41,665	(1)	100,000	I	See Footnote (5)
Series C Preferred Stock	(1)	07/28/2015		C			100,000	(1)	(1)	Common Stock	41,665	(1)	0	I	See Footnote (6)

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
SCHULER JACK W C/O NEOS THERAPEUTICS, INC. 2940 N. HWY 360 GRAND PRAIRIE, TX 75050		X

Signatures

/s/ Benjamin Piper, attorney-in-fact		07/28/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Each share of the Issuer's Series B preferred stock, Series B-1 preferred stock and Series C preferred stock was automatically converted on a 2.4-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering. The shares of Series B preferred stock, Series B-1 preferred stock and Series C preferred stock had no expiration date.
(2)	Security listed in column 1 is directly held by JS Grandchildren 2010 Continuation Trust. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
(3)	Security listed in column 1 is directly held by Schuler Grandchildren LLC. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
(4)	Security listed in column 1 is directly held by Tanya Eve Schuler Trust. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
(5)	Security listed in column 1 is directly held by Tino Hans Schuler Trust. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
(6)	Security listed in column 1 is directly held by Schuler Grandchildren LLC. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
(7)	Security listed in column 1 is directly held by Jack W. Schuler Living Trust, of which the Reporting Person is the sole trustee. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.